| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |